Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Cetuximab> ?p ?o }
- Cetuximab abstract "Cetuximab (INN) is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer. Cetuximab is a chimeric (mouse/human) monoclonal antibody given by intravenous infusion that is distributed under the trade name Erbitux in the U.S. and Canada by the drug company Bristol-Myers Squibb and outside the U.S. and Canada by the drug company Merck KGaA. In Japan, Merck KGaA, Bristol-Myers Squibb and Eli Lilly have a co-distribution.In July 2009, the FDA approved cetuximab (Erbitux) for treatment of colon cancer with wild-type KRAS, since it had little or no effect in colorectal tumors harboring a KRAS mutation (this also applied to the EGFR antibody panitumumab) This was the first genetic test to guide treatment of cancer. In July 2012, the FDA approved a real time PCR companion diagnostic test for KRAS, the therascreen KRAS test.".
- Cetuximab atcPrefix "L01".
- Cetuximab atcSuffix "XC06".
- Cetuximab casNumber "205923-56-4".
- Cetuximab drugbank "DB00002".
- Cetuximab fdaUniiCode "PQX0D8J21J".
- Cetuximab thumbnail Cetuximab.png?width=300.
- Cetuximab wikiPageExternalLink www.erbitux.com.
- Cetuximab wikiPageExternalLink ucm113714.htm.
- Cetuximab wikiPageID "1599887".
- Cetuximab wikiPageLength "18039".
- Cetuximab wikiPageOutDegree "56".
- Cetuximab wikiPageRevisionID "705746896".
- Cetuximab wikiPageWikiLink Anaphylaxis.
- Cetuximab wikiPageWikiLink Biosimilar.
- Cetuximab wikiPageWikiLink Bristol-Myers_Squibb.
- Cetuximab wikiPageWikiLink Category:Bristol-Myers_Squibb.
- Cetuximab wikiPageWikiLink Category:Eli_Lilly_and_Company.
- Cetuximab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Cetuximab wikiPageWikiLink Cell_surface_receptor.
- Cetuximab wikiPageWikiLink Chills.
- Cetuximab wikiPageWikiLink Colorectal_cancer.
- Cetuximab wikiPageWikiLink Committee_for_Medicinal_Products_for_Human_Use.
- Cetuximab wikiPageWikiLink Companion_diagnostic.
- Cetuximab wikiPageWikiLink Diphenhydramine.
- Cetuximab wikiPageWikiLink Eli_Lilly_and_Company.
- Cetuximab wikiPageWikiLink Epidermal_growth_factor_receptor.
- Cetuximab wikiPageWikiLink Food_and_Drug_Administration.
- Cetuximab wikiPageWikiLink Growth_factor.
- Cetuximab wikiPageWikiLink Head_and_neck_cancer.
- Cetuximab wikiPageWikiLink Hypomagnesemia.
- Cetuximab wikiPageWikiLink ImClone_Systems.
- Cetuximab wikiPageWikiLink International_nonproprietary_name.
- Cetuximab wikiPageWikiLink Intravenous_therapy.
- Cetuximab wikiPageWikiLink Irinotecan.
- Cetuximab wikiPageWikiLink Itch.
- Cetuximab wikiPageWikiLink KRAS.
- Cetuximab wikiPageWikiLink List_of_cutaneous_conditions.
- Cetuximab wikiPageWikiLink Lung_cancer.
- Cetuximab wikiPageWikiLink Merck_Group.
- Cetuximab wikiPageWikiLink Michael_Sela.
- Cetuximab wikiPageWikiLink Mitogen-activated_protein_kinase.
- Cetuximab wikiPageWikiLink Monoclonal_antibody.
- Cetuximab wikiPageWikiLink Oxaliplatin.
- Cetuximab wikiPageWikiLink Panitumumab.
- Cetuximab wikiPageWikiLink Polymerase_chain_reaction.
- Cetuximab wikiPageWikiLink Radiation_therapy.
- Cetuximab wikiPageWikiLink Rhône-Poulenc.
- Cetuximab wikiPageWikiLink Squamous-cell_carcinoma.
- Cetuximab wikiPageWikiLink Stomach_cancer.
- Cetuximab wikiPageWikiLink Urticaria.
- Cetuximab wikiPageWikiLink Weizmann_Institute_of_Science.
- Cetuximab wikiPageWikiLinkText "Cetuximab".
- Cetuximab wikiPageWikiLinkText "Erbitux".
- Cetuximab wikiPageWikiLinkText "cetuximab".
- Cetuximab atcPrefix "L01".
- Cetuximab atcSuffix "XC06".
- Cetuximab c "6484".
- Cetuximab casNumber "205923".
- Cetuximab chembl "1201577".
- Cetuximab chemspiderid "none".
- Cetuximab drugbank "DB00002".
- Cetuximab eliminationHalfLife "410400.0".
- Cetuximab h "10042".
- Cetuximab kegg "D03455".
- Cetuximab legalAu "S4".
- Cetuximab legalCa "Rx-only".
- Cetuximab legalUk "POM".
- Cetuximab legalUs "Rx-only".
- Cetuximab licenceEu "Erbitux".
- Cetuximab licenceUs "Cetuximab".
- Cetuximab mabType "mab".
- Cetuximab molecularWeight "145781.6".
- Cetuximab n "1732".
- Cetuximab o "2023".
- Cetuximab pregnancyAu "D".
- Cetuximab pregnancyUs "C".
- Cetuximab routesOfAdministration Intravenous_therapy.
- Cetuximab s "36".
- Cetuximab source "xi/o".
- Cetuximab target Epidermal_growth_factor_receptor.
- Cetuximab tradename "Erbitux".
- Cetuximab type "mab".
- Cetuximab unii "PQX0D8J21J".
- Cetuximab verifiedfields "changed".
- Cetuximab verifiedrevid "460026782".
- Cetuximab wikiPageUsesTemplate Template:Cascite.
- Cetuximab wikiPageUsesTemplate Template:Chemspidercite.
- Cetuximab wikiPageUsesTemplate Template:Citation_needed.
- Cetuximab wikiPageUsesTemplate Template:Drugbankcite.
- Cetuximab wikiPageUsesTemplate Template:Drugbox.
- Cetuximab wikiPageUsesTemplate Template:Drugs.com.
- Cetuximab wikiPageUsesTemplate Template:Ebicite.
- Cetuximab wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Cetuximab wikiPageUsesTemplate Template:Fdacite.
- Cetuximab wikiPageUsesTemplate Template:Keggcite.
- Cetuximab wikiPageUsesTemplate Template:Mcn.
- Cetuximab wikiPageUsesTemplate Template:Medref.
- Cetuximab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Cetuximab wikiPageUsesTemplate Template:Reflist.